The Joint United Nations Programme on HIV/AIDS (UNAIDS) has launched a new framework to accelerate action in reaching 15 million people with antiretroviral treatment by 2015––the goal set by United Nations Member States in 2011.
Researchers at the USC Norris Comprehensive Cancer Center have discovered a promising new way to treat a rare and aggressive blood cancer most commonly found in people infected with HIV.
More than a decade after the African Union drew up the Abuja Declaration on HIV/AIDS, Tuberculosis and Other Related Infectious Diseases, how have governments fared in their commitments to increase domestic health spending and scale up local efforts to fight these infectious diseases?
Determined to establish a facility that should enable all Nigerian workers to be able to access confidential testing of Human Immuno-deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS) across the nation, the Nigeria Labour Congress in collaboration with the National Agency for the Control of AIDS (NACA) has inaugurated NLC Mobile Voluntary Confidential Counselling and Testing (VCCT).
According to UNAIDS, the world is "closing in" on its Millennium Development Goals to stop and reverse the Aids epidemic by 2015. The number of HIV infections and Aids-related deaths has fallen dramatically, according to a UN report. Death rates fell from 2.3 million during its peak in 2005 to 1.6 million last year, says UNAIDS.The number of new HIV infections fell by a third since 2001 to 2.3 million.
A major new finding that will significantly advance efforts to create the world's first antibody-based AIDS vaccine was recently published by researchers from the La Jolla Institute for Allergy and Immunology.
The National HIV/AIDS Resource Centre (NHRC) of Nigeria is a platform to generate, share and use information strategically by all stakeholders within the HIV and AIDS National Response. The NHRC houses a comprehensive data base of information generated in Nigeria in the area of HIV/AIDS and allied areas to facilitate easy online access and use by the administrators, policy makers, research scholars, health care professionals, programme personnel and the general public.